Latest Transformation News

Gateway Mining Ltd has agreed to acquire Strickland Metals’ Yandal Gold Project for $45 million in shares, significantly expanding its gold resource base and exploration potential in Western Australia.

Killi Resources continues to build momentum at its Mt Rawdon West and West Tanami projects, progressing exploration and preparing for drilling while maintaining a solid cash position.

Riedel Resources Limited has progressed its Kingman Project in Arizona, securing $1.4 million in fresh capital to fund drilling and development activities at the high-grade Tintic deposit. The company also strengthened its board with the appointment of an experienced independent director.

ENRG Elements Limited has appointed new management and implemented significant cost reductions while renewing key uranium exploration permits in Niger. The company is also exiting lithium projects in Canada to focus on core assets and new opportunities.

Zoono Group Limited reports strong progress in its shelf-life extension technology with 45 active trials worldwide and anticipates UK revenue by Q2 FY26 following successful supermarket partnerships.

Minbos Resources has secured key financing and made significant construction strides on its Angolan phosphate fertilizer plant, while rolling out promising new fertilizer blends to support local agriculture.

Beonic has landed a landmark AU$15.2 million contract to deploy its LiDAR passenger flow technology across seven major North African airports, marking a strategic expansion into the region ahead of a major 2030 sporting event.

Artemis Resources has secured $4.75 million in funding to launch a major drilling campaign across its gold, copper, and lithium projects in Western Australia, setting the stage for significant resource growth and development.

Radiopharm Theranostics reports significant progress in its oncology radiopharmaceutical pipeline, including FDA Fast Track designation and dose escalation approvals, supported by a solid cash runway through mid-2026.

Atomo Diagnostics reports strong commercial momentum in Q4 FY25, highlighted by a major US supply agreement, rapid growth in HIV self-test sales, and promising data for its syphilis test.

Spenda Limited has reported a record-breaking FY25 with cash receipts soaring 114% to $11.5 million and launched its APG Pay platform backed by a $50 million funding commitment. The company also trimmed operating costs by 39%, setting a leaner foundation for FY26 growth.

Syntara Limited has initiated dosing in its Phase 1a/b trial for SNT-9465, a topical drug targeting hypertrophic scars, aiming to offer a non-invasive alternative to current treatments. Results expected in early 2026 could pave the way for global development and FDA approval.